BioLife Solutions Inc (BLFS)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 18,311 20,937 23,572 23,692 23,793 24,207 6,188 6,313 6,353 6,122 5,019 916 655
Total stockholders’ equity US$ in thousands 337,663 332,017 352,128 358,107 364,188 405,120 409,544 476,075 478,047 489,259 452,281 208,777 204,429 186,851 105,843 67,709 43,321 35,191 2,072 -3,740
Debt-to-capital ratio 0.05 0.06 0.06 0.06 0.06 0.06 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $18,311K ÷ ($18,311K + $337,663K)
= 0.05

The debt-to-capital ratio of BioLife Solutions Inc has been relatively stable over the past few quarters, hovering between 0.00 and 0.06. This indicates that the company has maintained a conservative approach to financing its operations, with a low level of debt relative to its total capital. The sudden increase from 0.00 in the first quarter of 2022 to 0.06 in the second quarter of 2022 could be a result of a significant change in the capital structure, possibly due to new debt issuance or a decrease in equity. However, the ratio quickly decreased back to 0.01 in subsequent quarters, suggesting a return to the previous capital structure. Overall, the consistent low debt-to-capital ratio reflects a financially healthy position for BioLife Solutions Inc, indicating lower financial risk and a stable foundation for future growth.


Peer comparison

Dec 31, 2023